## American Public Education, Inc. (APEI) — deep dive (filings-first) ### What you’re looking at (the “map”) Use this as a self-guided, “pick-a-module” research notebook: 1) **Business model & segments** (who earns what, and why) 2) **Operating scoreboard** (P&L, segment margins, mix shifts) 3) **Cash + balance sheet** (liquidity, leverage, capital allocation) 4) **Key operating KPIs** (registrations/enrollment) 5) **Funding/regulatory sensitivity** (Title IV / VA / DoD TA exposure) 6) **Risk catalysts & watch items** (government shutdown, combination plan, impairment headroom) All figures below are pulled from SEC filings/disclosures: the **Q3’25 Form 10‑Q** and the **Q3’25 earnings release filed as Exhibit 99.1 to an 8‑K**. (0001201792-25-000020|0) (0001104659-25-109265|1) --- ## 1) Business model & segment structure (how APEI actually makes money) APEI reports three education segments: - **APUS (American Public University System)**: online-focused; meaningful military-affiliated exposure (DoD Tuition Assistance + VA benefits). ["APUS Segment"](0001201792-25-000020|0) - **RU (Rasmussen University)**: nursing/health sciences focused with campus + online footprint; heavy **Title IV** funding mix. ["RU Segment"](0001201792-25-000020|0) - **HCN (Hondros College of Nursing)**: pre-licensure nursing; also heavily **Title IV** funded. ["HCN Segment"](0001201792-25-000020|0) A key structural change in 2025: GSUSA is referenced as sold (and appears in “Corporate and Other” historically), and the company recorded a **loss on sale of subsidiary**. ["sale of its membership interest in GSUSA"](0001201792-25-000020|0) --- ## 2) Operating scoreboard — consolidated P&L (Q3 and 9M) ### Consolidated income statement snapshot (USD millions; computed from “in thousands”) | Metric | Q3 2025 | Q3 2024 | YoY | |---|---:|---:|---:| | Revenue | 163.215 ["Total revenue | $ | 163,215"](0001201792-25-000020|0) | 153.122 ["Total revenue | $ | 153,122"](0001201792-25-000020|0) | 6.6% (computed) ["163,215"](0001201792-25-000020|0) ["153,122"](0001201792-25-000020|0) | | Income from ops (before interest & taxes) | 9.697 ["Income from operations before interest"](0001201792-25-000020|0) | 4.129 ["Income from operations before interest"](0001201792-25-000020|0) | 134.9% (computed) ["9,697"](0001201792-25-000020|0) ["4,129"](0001201792-25-000020|0) | | Net income | 5.560 ["Net income | $ | 5,560"](0001201792-25-000020|0) | 2.262 ["Net income | $ | 2,262"](0001201792-25-000020|0) | 145.8% (computed) ["5,560"](0001201792-25-000020|0) ["2,262"](0001201792-25-000020|0) | | Net income to common | 5.560 ["Net income (loss) available to common stockholders"](0001201792-25-000020|0) | 0.731 ["Net income (loss) available to common stockholders"](0001201792-25-000020|0) | 660.6% (computed) ["5,560"](0001201792-25-000020|0) ["731"](0001201792-25-000020|0) | **Interpretation:** Q3 shows a “cleaner” earnings profile largely because preferred dividends are gone after the Series A preferred redemption (see capital structure section), and RU’s losses are much smaller than last year. ["no shares of preferred stock"](0001201792-25-000020|0) ["RU Segment | (1,240)"](0001201792-25-000020|0) --- ## 3) Segment economics & mix shifts (the most important table) ### Revenue by segment (USD millions; “in thousands” source) | Segment | Q3 2025 | Q3 2024 | YoY | |---|---:|---:|---:| | APUS | 83.137 ["APUS | ... | Total Revenue | $ | 83,137"](0001201792-25-000020|0) | 76.981 ["APUS | ... | Total Revenue | $ | 76,981"](0001201792-25-000020|0) | 8.0% (computed) ["83,137"](0001201792-25-000020|0) ["76,981"](0001201792-25-000020|0) | | RU | 60.830 ["RU | ... | Total Revenue | $ | 60,830"](0001201792-25-000020|0) | 52.604 ["RU | ... | Total Revenue | $ | 52,604"](0001201792-25-000020|0) | 15.6% (computed) ["60,830"](0001201792-25-000020|0) ["52,604"](0001201792-25-000020|0) | | HCN | 18.440 ["HCN | ... | Total Revenue | $ | 18,440"](0001201792-25-000020|0) | 15.493 ["HCN | ... | Total Revenue | $ | 15,493"](0001201792-25-000020|0) | 19.0% (computed) ["18,440"](0001201792-25-000020|0) ["15,493"](0001201792-25-000020|0) | | Corporate/Other | 0.808 ["Corporate and Other | 808"](0001201792-25-000020|0) | 8.044 ["Corporate and Other | 8,044"](0001201792-25-000020|0) | (89.9%) (computed) ["808"](0001201792-25-000020|0) ["8,044"](0001201792-25-000020|0) | | Consolidated | 163.215 ["Total revenue | $ | 163,215"](0001201792-25-000020|0) | 153.122 ["Total revenue | $ | 153,122"](0001201792-25-000020|0) | 6.6% (computed) ["163,215"](0001201792-25-000020|0) ["153,122"](0001201792-25-000020|0) | **Read-through:** The mix shift in “Corporate and Other” is consistent with GSUSA being sold (corporate/other revenue collapsing). ["GSUSA (sold in July 2025)"](0001104659-25-109265|1) ### Segment operating income (loss) before interest & taxes (USD millions) | Segment | Q3 2025 | Q3 2024 | Δ | |---|---:|---:|---:| | APUS | 25.280 ["APUS Segment | $ | 25,280"](0001201792-25-000020|0) | 20.765 ["APUS Segment | $ | 20,765"](0001201792-25-000020|0) | +4.515 (computed) ["25,280"](0001201792-25-000020|0) ["20,765"](0001201792-25-000020|0) | | RU | (1.240) ["RU Segment | (1,240)"](0001201792-25-000020|0) | (7.609) ["RU Segment | (7,609)"](0001201792-25-000020|0) | +6.369 (computed) ["(1,240)"](0001201792-25-000020|0) ["(7,609)"](0001201792-25-000020|0) | | HCN | (0.873) ["HCN Segment | (873)"](0001201792-25-000020|0) | (0.771) ["HCN Segment | (771)"](0001201792-25-000020|0) | (0.102) (computed) ["(873)"](0001201792-25-000020|0) ["(771)"](0001201792-25-000020|0) | | Corporate/Other | (13.470) ["Corporate and Other | (13,470)"](0001201792-25-000020|0) | (8.256) ["Corporate and Other | (8,256)"](0001201792-25-000020|0) | (5.214) (computed) ["(13,470)"](0001201792-25-000020|0) ["(8,256)"](0001201792-25-000020|0) | | Total | 9.697 ["Total income from operations"](0001201792-25-000020|0) | 4.129 ["Total income from operations"](0001201792-25-000020|0) | +5.568 (computed) ["9,697"](0001201792-25-000020|0) ["4,129"](0001201792-25-000020|0) | **The core equity story (as of Q3’25):** - **APUS is the profit engine** (high and expanding segment operating margin per management commentary in the 10‑Q). ["APUS Segment operating margin increased to 30.4%"](0001201792-25-000020|0) - **RU is the swing factor**: still slightly loss-making at the operating line in Q3, but dramatically improved vs last year. ["RU Segment operating margin improved to negative 2.0%"](0001201792-25-000020|0) - **HCN is growing fast but still slightly negative** at the segment operating line (in Q3). ["HCN Segment | (873)"](0001201792-25-000020|0) --- ## 4) Cash + balance sheet — liquidity, leverage, and capital allocation ### Balance sheet highlights (USD millions) | Item | Sep 30, 2025 | Dec 31, 2024 | Comment | |---|---:|---:|---| | Cash, cash eq., restricted cash | 193.144 ["Cash, cash equivalents, and restricted cash ... 193,144"](0001201792-25-000020|0) | 158.941 ["... 158,941"](0001201792-25-000020|0) | +34.203 (computed) ["193,144"](0001201792-25-000020|0) ["158,941"](0001201792-25-000020|0) | | Total debt (net) | 94.368 ["Long-term debt, net | 94,368"](0001201792-25-000020|0) | 93.424 ["Long-term debt, net | 93,424"](0001201792-25-000020|0) | Floating-rate Term SOFR + margin. ["Facilities’ borrowing rate was 9.93%"](0001201792-25-000020|0) | | Preferred stock | 0.000 ["Preferred stock ... | —"](0001201792-25-000020|0) | 39.691 ["Preferred stock ... 39,691"](0001201792-25-000020|0) | Redeemed in June 2025. ["redeemed all 400 outstanding shares"](0001201792-25-000020|0) | **Two important “quality of cash” notes:** - Restricted cash fell sharply because a **$25.4m restricted certificate of deposit** tied to RU’s ED letter of credit was released in May 2025. ["letter of credit was released by ED"](0001201792-25-000020|0) - The earnings release emphasizes the balance sheet is “no net debt” and cites **$193.1m cash/cash eq/restricted cash** at Sep 30, 2025. ["no net debt"](0001104659-25-109265|1) ["$193.1 million of cash"](0001104659-25-109265|1) ### Cash flow (nine months ended Sep 30; USD millions) | Metric | 9M 2025 | 9M 2024 | Δ | |---|---:|---:|---:| | Operating cash flow | 73.516 ["Net cash provided by operating activities | 73,516"](0001201792-25-000020|0) | 47.273 ["... | 47,273"](0001201792-25-000020|0) | +26.243 (computed) ["73,516"](0001201792-25-000020|0) ["47,273"](0001201792-25-000020|0) | | Capex | (11.796) ["Capital expenditures | (11,796)"](0001201792-25-000020|0) | (17.728) ["Capital expenditures | (17,728)"](0001201792-25-000020|0) | +5.932 (computed) ["(11,796)"](0001201792-25-000020|0) ["(17,728)"](0001201792-25-000020|0) | | Proceeds: sale of real property | 22.959 ["Proceeds from the sale of real property | 22,959"](0001201792-25-000020|0) | 0.000 ["Proceeds ... | —"](0001201792-25-000020|0) | +22.959 (computed) ["22,959"](0001201792-25-000020|0) | | Redemption of preferred stock | (43.192) ["Cash paid for redemption of preferred stock | (43,192)"](0001201792-25-000020|0) | 0.000 ["... | —"](0001201792-25-000020|0) | (43.192) (computed) ["(43,192)"](0001201792-25-000020|0) | **Read-through:** Operating cash generation improved materially Y/Y, and 2025 investing cash flow is boosted by property sale proceeds, while financing cash is weighed down by the preferred redemption. ["Net cash provided by operating activities was $73.5 million"](0001201792-25-000020|0) ["proceeds from the sale of real property"](0001201792-25-000020|0) ["redeemed ... Series A Senior Preferred Stock"](0001201792-25-000020|0) --- ## 5) Operating KPIs — registrations & enrollment (your “demand dashboard”) From the earnings release (Q3): | KPI | Q3 2025 | Q3 2024 | YoY | |---|---:|---:|---:| | APUS net course registrations | 100,000 ["Net Course Registrations | 100,000"](0001104659-25-109265|1) | 92,500 ["... | 92,500"](0001104659-25-109265|1) | 8.1% ["8.1%"](0001104659-25-109265|1) | | RU total student enrollment | 14,900 ["Total Student Enrollment | 14,900"](0001104659-25-109265|1) | 13,500 ["... | 13,500"](0001104659-25-109265|1) | 10.4% ["10.4%"](0001104659-25-109265|1) | | HCN total student enrollment | 3,700 ["Total Student Enrollment | 3,700"](0001104659-25-109265|1) | 3,100 ["... | 3,100"](0001104659-25-109265|1) | 17.6% ["17.6%"](0001104659-25-109265|1) | **Why these KPIs matter:** In the 10‑Q segment discussion, APUS revenue growth is tied to “higher net course registrations,” and HCN growth is tied to higher total student enrollment. ["increase ... in revenue ... primarily attributable to higher net course registrations"](0001201792-25-000020|0) ["increase ... in revenue ... primarily due to a 17.6% increase"](0001201792-25-000020|0) --- ## 6) Funding & regulatory sensitivity (where the “real risk” lives) ### Funding mix by segment (shares of revenue; 10‑Q) This is a compact way to see exposure to federal programs: | Segment | DoD TA | VA benefits | Title IV | Cash/Other | |---|---:|---:|---:|---:| | APUS (Q3’25) | 42% ["DoD tuition assistance programs | 42%"](0001201792-25-000020|0) | 26% ["VA education benefits | 26%"](0001201792-25-000020|0) | 18% ["Title IV programs | 18%"](0001201792-25-000020|0) | 14% ["Cash and other sources | 14%"](0001201792-25-000020|0) | | RU (Q3’25) | — | 2% ["VA education benefits | 2%"](0001201792-25-000020|0) | 78% ["Title IV programs | 78%"](0001201792-25-000020|0) | 20% ["Cash and other sources | 20%"](0001201792-25-000020|0) | | HCN (Q3’25) | — | 1% ["VA education benefits | 1%"](0001201792-25-000020|0) | 84% ["Title IV programs | 84%"](0001201792-25-000020|0) | 15% ["Cash and other sources | 15%"](0001201792-25-000020|0) | **Implication:** - **APUS** is highly sensitive to **DoD TA** + **VA** continuity. ["DoD tuition assistance programs | 42%"](0001201792-25-000020|0) - **RU/HCN** are structurally sensitive to **Title IV policy and compliance**. ["Title IV programs | 78%"](0001201792-25-000020|0) ["Title IV programs | 84%"](0001201792-25-000020|0) --- ## 7) Risk catalysts & “what to watch” (near-term and structural) ### A) Government shutdown impact (APUS demand shock) APEI discloses that **DoD TA programs were temporarily suspended on Oct 1, 2025** due to a U.S. federal government shutdown. ["DoD TA programs were temporarily suspended"](0001201792-25-000020|0) They quantify immediate fallout: - ~**12,700 APUS course registrations were dropped** on Oct 11, 2025 (intended TA users). ["approximately 12,700 APUS course registrations were dropped"](0001201792-25-000020|0) - October 2025 net course registrations estimated **down ~35% vs Oct 2024**. ["net course registrations declined by approximately 35%"](0001201792-25-000020|0) - Mitigation actions include **reduction in force, hiring freeze, and cuts to travel/discretionary spending**. ["reduction in force, hiring freeze"](0001201792-25-000020|0) **How this hits the model:** APUS is profitable and large; a sustained TA disruption can be a direct revenue/margin headwind even if RU/HCN are performing. ["APUS Segment | $ | 83,137"](0001201792-25-000020|0) ["APUS Segment | $ | 25,280"](0001201792-25-000020|0) ### B) “Combination” initiative (integration/execution risk) APEI discusses a planned combination of APUS, RU, and HCN “into one consolidated institution.” ["planned combination of ... into one consolidated institution"](0001201792-25-000020|0) This matters because it can: - create cost synergies and unified systems, **or** - create operational disruption/compliance risk (especially across accrediting and Title IV frameworks). ["accrediting agency requirements"](0001201792-25-000020|0) ### C) Goodwill / intangible impairment headroom (RU + HCN) APEI reports that its annual assessment concluded RU and HCN **fair value exceeded carrying value by ~$71.9m (62%) and ~$8.6m (24%)**, respectively. ["exceeded their carrying values by approximately $71.9 million, or 62%"](0001201792-25-000020|0) ["$8.6 million, or 24%"](0001201792-25-000020|0) **Interpretation:** RU has larger headroom; HCN’s smaller headroom means it could become the earlier impairment watch item if performance deteriorates. ### D) Debt & interest-rate exposure (but covenant looks fine today) Key terms disclosed in the 10‑Q: - Term loan original principal: **$175.0m**, maturity **Sep 1, 2027**; revolver **$20.0m** to **Sep 1, 2026**. ["term loan facility ... $175.0 million"](0001201792-25-000020|0) ["scheduled maturity date of September 1, 2027"](0001201792-25-000020|0) ["revolving loan facility ... $20.0 million"](0001201792-25-000020|0) - As of Sep 30, 2025 borrowing rate disclosed: **9.93%**. ["borrowing rate was 9.93%"](0001201792-25-000020|0) - Covenant: Total Net Leverage Ratio ≤ **2.00x**; company says it was in compliance. ["Total Net Leverage Ratio of no greater than 2.00 to 1.00"](0001201792-25-000020|0) ["in compliance with all debt covenants"](0001201792-25-000020|0) --- ## 8) Guidance (management’s forward frame from the 8‑K earnings release) ### Q4 2025 guidance (as disclosed) | Metric | Guidance range | |---|---:| | Consolidated revenue (USD m) | 150.0 – 153.5 ["APEI Consolidated revenue | $150.0 – $153.5"](0001104659-25-109265|1) | | Net income to common (USD m) | 5.9 – 8.3 ["Net income available to common stockholders | $5.9 – $8.3"](0001104659-25-109265|1) | | Adjusted EBITDA (USD m) | 18.5 – 22.0 ["Adjusted EBITDA | $18.5 – $22.0"](0001104659-25-109265|1) | | Diluted EPS (USD) | 0.32 – 0.45 ["Diluted EPS | $0.32 – $0.45"](0001104659-25-109265|1) | ### Full-year 2025 guidance (as disclosed) | Metric | Guidance range | |---|---:| | Consolidated revenue (USD m) | 640 – 644 ["APEI Consolidated Revenue | $640 – $644"](0001104659-25-109265|1) | | Net income to common (USD m) | 17.2 – 19.6 ["Net income available to common stockholders | $17.2 – $19.6"](0001104659-25-109265|1) | | Adjusted EBITDA (USD m) | 75 – 79 ["Adjusted EBITDA | $75 – $79"](0001104659-25-109265|1) | | Capex (USD m) | 15 – 17 ["Capital Expenditure (CapEx) | $15 – $17"](0001104659-25-109265|1) | --- ## Bottom line (how I’d summarize the APEI setup from these disclosures) APEI’s Q3’25 disclosures show a company with **(1) strong cash generation, (2) APUS-driven profitability, (3) improving RU economics, and (4) fast-growing HCN enrollment**, alongside a very specific near-term macro/regulatory catalyst: the **DoD TA disruption tied to the government shutdown**, which management quantifies as an October registration shock and is actively cost-mitigating. ["Net cash provided by operating activities | 73,516"](0001201792-25-000020|0) ["APUS Segment | $ | 25,280"](0001201792-25-000020|0) ["RU Segment operating margin improved"](0001201792-25-000020|0) ["Total Student Enrollment | 3,700"](0001104659-25-109265|1) ["net course registrations declined by approximately 35%"](0001201792-25-000020|0) If you want to continue the “interactive” dive on your own, the next high-signal sections inside the same 10‑Q are: - **MD&A liquidity + shutdown mitigation** ["Liquidity"](0001201792-25-000020|0) - **Segment drivers (APUS registrations / RU enrollment mix / HCN enrollment)** ["Net course registrations increased"](0001201792-25-000020|0) - **Funding source sensitivity tables (TA/VA/Title IV)** ["derived from students by primary funding source"](0001201792-25-000020|0)

## American Public Education, Inc. (APEI) — deep dive (filings-first) ### What you’re looking at (the “map”) Use this as a self-guided, “pick-a-module” research notebook: 1) **Business model & segments** (who earns what, and why) 2) **Operating scoreboard** (P&L, segment margins, mix shifts) 3) **Cash + balance sheet** (liquidity, leverage, capital allocation) 4) **Key operating KPIs** (registrations/enrollment) 5) **Funding/regulatory sensitivity** (Title IV / VA / DoD TA exposure) 6) **Risk catalysts & watch items** (government shutdown, combination plan, impairment headroom) All figures below are pulled from SEC filings/disclosures: the **Q3’25 Form 10‑Q** and the **Q3’25 earnings release filed as Exhibit 99.1 to an 8‑K**. (0001201792-25-000020|0) (0001104659-25-109265|1) --- ## 1) Business model & segment structure (how APEI actually makes money) APEI reports three education segments: - **APUS (American Public University System)**: online-focused; meaningful military-affiliated exposure (DoD Tuition Assistance + VA benefits). ["APUS Segment"](0001201792-25-000020|0) - **RU (Rasmussen University)**: nursing/health sciences focused with campus + online footprint; heavy **Title IV** funding mix. ["RU Segment"](0001201792-25-000020|0) - **HCN (Hondros College of Nursing)**: pre-licensure nursing; also heavily **Title IV** funded. ["HCN Segment"](0001201792-25-000020|0) A key structural change in 2025: GSUSA is referenced as sold (and appears in “Corporate and Other” historically), and the company recorded a **loss on sale of subsidiary**. ["sale of its membership interest in GSUSA"](0001201792-25-000020|0) --- ## 2) Operating scoreboard — consolidated P&L (Q3 and 9M) ### Consolidated income statement snapshot (USD millions; computed from “in thousands”) | Metric | Q3 2025 | Q3 2024 | YoY | |---|---:|---:|---:| | Revenue | 163.215 ["Total revenue | $ | 163,215"](0001201792-25-000020|0) | 153.122 ["Total revenue | $ | 153,122"](0001201792-25-000020|0) | 6.6% (computed) ["163,215"](0001201792-25-000020|0) ["153,122"](0001201792-25-000020|0) | | Income from ops (before interest & taxes) | 9.697 ["Income from operations before interest"](0001201792-25-000020|0) | 4.129 ["Income from operations before interest"](0001201792-25-000020|0) | 134.9% (computed) ["9,697"](0001201792-25-000020|0) ["4,129"](0001201792-25-000020|0) | | Net income | 5.560 ["Net income | $ | 5,560"](0001201792-25-000020|0) | 2.262 ["Net income | $ | 2,262"](0001201792-25-000020|0) | 145.8% (computed) ["5,560"](0001201792-25-000020|0) ["2,262"](0001201792-25-000020|0) | | Net income to common | 5.560 ["Net income (loss) available to common stockholders"](0001201792-25-000020|0) | 0.731 ["Net income (loss) available to common stockholders"](0001201792-25-000020|0) | 660.6% (computed) ["5,560"](0001201792-25-000020|0) ["731"](0001201792-25-000020|0) | **Interpretation:** Q3 shows a “cleaner” earnings profile largely because preferred dividends are gone after the Series A preferred redemption (see capital structure section), and RU’s losses are much smaller than last year. ["no shares of preferred stock"](0001201792-25-000020|0) ["RU Segment | (1,240)"](0001201792-25-000020|0) --- ## 3) Segment economics & mix shifts (the most important table) ### Revenue by segment (USD millions; “in thousands” source) | Segment | Q3 2025 | Q3 2024 | YoY | |---|---:|---:|---:| | APUS | 83.137 ["APUS | ... | Total Revenue | $ | 83,137"](0001201792-25-000020|0) | 76.981 ["APUS | ... | Total Revenue | $ | 76,981"](0001201792-25-000020|0) | 8.0% (computed) ["83,137"](0001201792-25-000020|0) ["76,981"](0001201792-25-000020|0) | | RU | 60.830 ["RU | ... | Total Revenue | $ | 60,830"](0001201792-25-000020|0) | 52.604 ["RU | ... | Total Revenue | $ | 52,604"](0001201792-25-000020|0) | 15.6% (computed) ["60,830"](0001201792-25-000020|0) ["52,604"](0001201792-25-000020|0) | | HCN | 18.440 ["HCN | ... | Total Revenue | $ | 18,440"](0001201792-25-000020|0) | 15.493 ["HCN | ... | Total Revenue | $ | 15,493"](0001201792-25-000020|0) | 19.0% (computed) ["18,440"](0001201792-25-000020|0) ["15,493"](0001201792-25-000020|0) | | Corporate/Other | 0.808 ["Corporate and Other | 808"](0001201792-25-000020|0) | 8.044 ["Corporate and Other | 8,044"](0001201792-25-000020|0) | (89.9%) (computed) ["808"](0001201792-25-000020|0) ["8,044"](0001201792-25-000020|0) | | Consolidated | 163.215 ["Total revenue | $ | 163,215"](0001201792-25-000020|0) | 153.122 ["Total revenue | $ | 153,122"](0001201792-25-000020|0) | 6.6% (computed) ["163,215"](0001201792-25-000020|0) ["153,122"](0001201792-25-000020|0) | **Read-through:** The mix shift in “Corporate and Other” is consistent with GSUSA being sold (corporate/other revenue collapsing). ["GSUSA (sold in July 2025)"](0001104659-25-109265|1) ### Segment operating income (loss) before interest & taxes (USD millions) | Segment | Q3 2025 | Q3 2024 | Δ | |---|---:|---:|---:| | APUS | 25.280 ["APUS Segment | $ | 25,280"](0001201792-25-000020|0) | 20.765 ["APUS Segment | $ | 20,765"](0001201792-25-000020|0) | +4.515 (computed) ["25,280"](0001201792-25-000020|0) ["20,765"](0001201792-25-000020|0) | | RU | (1.240) ["RU Segment | (1,240)"](0001201792-25-000020|0) | (7.609) ["RU Segment | (7,609)"](0001201792-25-000020|0) | +6.369 (computed) ["(1,240)"](0001201792-25-000020|0) ["(7,609)"](0001201792-25-000020|0) | | HCN | (0.873) ["HCN Segment | (873)"](0001201792-25-000020|0) | (0.771) ["HCN Segment | (771)"](0001201792-25-000020|0) | (0.102) (computed) ["(873)"](0001201792-25-000020|0) ["(771)"](0001201792-25-000020|0) | | Corporate/Other | (13.470) ["Corporate and Other | (13,470)"](0001201792-25-000020|0) | (8.256) ["Corporate and Other | (8,256)"](0001201792-25-000020|0) | (5.214) (computed) ["(13,470)"](0001201792-25-000020|0) ["(8,256)"](0001201792-25-000020|0) | | Total | 9.697 ["Total income from operations"](0001201792-25-000020|0) | 4.129 ["Total income from operations"](0001201792-25-000020|0) | +5.568 (computed) ["9,697"](0001201792-25-000020|0) ["4,129"](0001201792-25-000020|0) | **The core equity story (as of Q3’25):** - **APUS is the profit engine** (high and expanding segment operating margin per management commentary in the 10‑Q). ["APUS Segment operating margin increased to 30.4%"](0001201792-25-000020|0) - **RU is the swing factor**: still slightly loss-making at the operating line in Q3, but dramatically improved vs last year. ["RU Segment operating margin improved to negative 2.0%"](0001201792-25-000020|0) - **HCN is growing fast but still slightly negative** at the segment operating line (in Q3). ["HCN Segment | (873)"](0001201792-25-000020|0) --- ## 4) Cash + balance sheet — liquidity, leverage, and capital allocation ### Balance sheet highlights (USD millions) | Item | Sep 30, 2025 | Dec 31, 2024 | Comment | |---|---:|---:|---| | Cash, cash eq., restricted cash | 193.144 ["Cash, cash equivalents, and restricted cash ... 193,144"](0001201792-25-000020|0) | 158.941 ["... 158,941"](0001201792-25-000020|0) | +34.203 (computed) ["193,144"](0001201792-25-000020|0) ["158,941"](0001201792-25-000020|0) | | Total debt (net) | 94.368 ["Long-term debt, net | 94,368"](0001201792-25-000020|0) | 93.424 ["Long-term debt, net | 93,424"](0001201792-25-000020|0) | Floating-rate Term SOFR + margin. ["Facilities’ borrowing rate was 9.93%"](0001201792-25-000020|0) | | Preferred stock | 0.000 ["Preferred stock ... | —"](0001201792-25-000020|0) | 39.691 ["Preferred stock ... 39,691"](0001201792-25-000020|0) | Redeemed in June 2025. ["redeemed all 400 outstanding shares"](0001201792-25-000020|0) | **Two important “quality of cash” notes:** - Restricted cash fell sharply because a **$25.4m restricted certificate of deposit** tied to RU’s ED letter of credit was released in May 2025. ["letter of credit was released by ED"](0001201792-25-000020|0) - The earnings release emphasizes the balance sheet is “no net debt” and cites **$193.1m cash/cash eq/restricted cash** at Sep 30, 2025. ["no net debt"](0001104659-25-109265|1) ["$193.1 million of cash"](0001104659-25-109265|1) ### Cash flow (nine months ended Sep 30; USD millions) | Metric | 9M 2025 | 9M 2024 | Δ | |---|---:|---:|---:| | Operating cash flow | 73.516 ["Net cash provided by operating activities | 73,516"](0001201792-25-000020|0) | 47.273 ["... | 47,273"](0001201792-25-000020|0) | +26.243 (computed) ["73,516"](0001201792-25-000020|0) ["47,273"](0001201792-25-000020|0) | | Capex | (11.796) ["Capital expenditures | (11,796)"](0001201792-25-000020|0) | (17.728) ["Capital expenditures | (17,728)"](0001201792-25-000020|0) | +5.932 (computed) ["(11,796)"](0001201792-25-000020|0) ["(17,728)"](0001201792-25-000020|0) | | Proceeds: sale of real property | 22.959 ["Proceeds from the sale of real property | 22,959"](0001201792-25-000020|0) | 0.000 ["Proceeds ... | —"](0001201792-25-000020|0) | +22.959 (computed) ["22,959"](0001201792-25-000020|0) | | Redemption of preferred stock | (43.192) ["Cash paid for redemption of preferred stock | (43,192)"](0001201792-25-000020|0) | 0.000 ["... | —"](0001201792-25-000020|0) | (43.192) (computed) ["(43,192)"](0001201792-25-000020|0) | **Read-through:** Operating cash generation improved materially Y/Y, and 2025 investing cash flow is boosted by property sale proceeds, while financing cash is weighed down by the preferred redemption. ["Net cash provided by operating activities was $73.5 million"](0001201792-25-000020|0) ["proceeds from the sale of real property"](0001201792-25-000020|0) ["redeemed ... Series A Senior Preferred Stock"](0001201792-25-000020|0) --- ## 5) Operating KPIs — registrations & enrollment (your “demand dashboard”) From the earnings release (Q3): | KPI | Q3 2025 | Q3 2024 | YoY | |---|---:|---:|---:| | APUS net course registrations | 100,000 ["Net Course Registrations | 100,000"](0001104659-25-109265|1) | 92,500 ["... | 92,500"](0001104659-25-109265|1) | 8.1% ["8.1%"](0001104659-25-109265|1) | | RU total student enrollment | 14,900 ["Total Student Enrollment | 14,900"](0001104659-25-109265|1) | 13,500 ["... | 13,500"](0001104659-25-109265|1) | 10.4% ["10.4%"](0001104659-25-109265|1) | | HCN total student enrollment | 3,700 ["Total Student Enrollment | 3,700"](0001104659-25-109265|1) | 3,100 ["... | 3,100"](0001104659-25-109265|1) | 17.6% ["17.6%"](0001104659-25-109265|1) | **Why these KPIs matter:** In the 10‑Q segment discussion, APUS revenue growth is tied to “higher net course registrations,” and HCN growth is tied to higher total student enrollment. ["increase ... in revenue ... primarily attributable to higher net course registrations"](0001201792-25-000020|0) ["increase ... in revenue ... primarily due to a 17.6% increase"](0001201792-25-000020|0) --- ## 6) Funding & regulatory sensitivity (where the “real risk” lives) ### Funding mix by segment (shares of revenue; 10‑Q) This is a compact way to see exposure to federal programs: | Segment | DoD TA | VA benefits | Title IV | Cash/Other | |---|---:|---:|---:|---:| | APUS (Q3’25) | 42% ["DoD tuition assistance programs | 42%"](0001201792-25-000020|0) | 26% ["VA education benefits | 26%"](0001201792-25-000020|0) | 18% ["Title IV programs | 18%"](0001201792-25-000020|0) | 14% ["Cash and other sources | 14%"](0001201792-25-000020|0) | | RU (Q3’25) | — | 2% ["VA education benefits | 2%"](0001201792-25-000020|0) | 78% ["Title IV programs | 78%"](0001201792-25-000020|0) | 20% ["Cash and other sources | 20%"](0001201792-25-000020|0) | | HCN (Q3’25) | — | 1% ["VA education benefits | 1%"](0001201792-25-000020|0) | 84% ["Title IV programs | 84%"](0001201792-25-000020|0) | 15% ["Cash and other sources | 15%"](0001201792-25-000020|0) | **Implication:** - **APUS** is highly sensitive to **DoD TA** + **VA** continuity. ["DoD tuition assistance programs | 42%"](0001201792-25-000020|0) - **RU/HCN** are structurally sensitive to **Title IV policy and compliance**. ["Title IV programs | 78%"](0001201792-25-000020|0) ["Title IV programs | 84%"](0001201792-25-000020|0) --- ## 7) Risk catalysts & “what to watch” (near-term and structural) ### A) Government shutdown impact (APUS demand shock) APEI discloses that **DoD TA programs were temporarily suspended on Oct 1, 2025** due to a U.S. federal government shutdown. ["DoD TA programs were temporarily suspended"](0001201792-25-000020|0) They quantify immediate fallout: - ~**12,700 APUS course registrations were dropped** on Oct 11, 2025 (intended TA users). ["approximately 12,700 APUS course registrations were dropped"](0001201792-25-000020|0) - October 2025 net course registrations estimated **down ~35% vs Oct 2024**. ["net course registrations declined by approximately 35%"](0001201792-25-000020|0) - Mitigation actions include **reduction in force, hiring freeze, and cuts to travel/discretionary spending**. ["reduction in force, hiring freeze"](0001201792-25-000020|0) **How this hits the model:** APUS is profitable and large; a sustained TA disruption can be a direct revenue/margin headwind even if RU/HCN are performing. ["APUS Segment | $ | 83,137"](0001201792-25-000020|0) ["APUS Segment | $ | 25,280"](0001201792-25-000020|0) ### B) “Combination” initiative (integration/execution risk) APEI discusses a planned combination of APUS, RU, and HCN “into one consolidated institution.” ["planned combination of ... into one consolidated institution"](0001201792-25-000020|0) This matters because it can: - create cost synergies and unified systems, **or** - create operational disruption/compliance risk (especially across accrediting and Title IV frameworks). ["accrediting agency requirements"](0001201792-25-000020|0) ### C) Goodwill / intangible impairment headroom (RU + HCN) APEI reports that its annual assessment concluded RU and HCN **fair value exceeded carrying value by ~$71.9m (62%) and ~$8.6m (24%)**, respectively. ["exceeded their carrying values by approximately $71.9 million, or 62%"](0001201792-25-000020|0) ["$8.6 million, or 24%"](0001201792-25-000020|0) **Interpretation:** RU has larger headroom; HCN’s smaller headroom means it could become the earlier impairment watch item if performance deteriorates. ### D) Debt & interest-rate exposure (but covenant looks fine today) Key terms disclosed in the 10‑Q: - Term loan original principal: **$175.0m**, maturity **Sep 1, 2027**; revolver **$20.0m** to **Sep 1, 2026**. ["term loan facility ... $175.0 million"](0001201792-25-000020|0) ["scheduled maturity date of September 1, 2027"](0001201792-25-000020|0) ["revolving loan facility ... $20.0 million"](0001201792-25-000020|0) - As of Sep 30, 2025 borrowing rate disclosed: **9.93%**. ["borrowing rate was 9.93%"](0001201792-25-000020|0) - Covenant: Total Net Leverage Ratio ≤ **2.00x**; company says it was in compliance. ["Total Net Leverage Ratio of no greater than 2.00 to 1.00"](0001201792-25-000020|0) ["in compliance with all debt covenants"](0001201792-25-000020|0) --- ## 8) Guidance (management’s forward frame from the 8‑K earnings release) ### Q4 2025 guidance (as disclosed) | Metric | Guidance range | |---|---:| | Consolidated revenue (USD m) | 150.0 – 153.5 ["APEI Consolidated revenue | $150.0 – $153.5"](0001104659-25-109265|1) | | Net income to common (USD m) | 5.9 – 8.3 ["Net income available to common stockholders | $5.9 – $8.3"](0001104659-25-109265|1) | | Adjusted EBITDA (USD m) | 18.5 – 22.0 ["Adjusted EBITDA | $18.5 – $22.0"](0001104659-25-109265|1) | | Diluted EPS (USD) | 0.32 – 0.45 ["Diluted EPS | $0.32 – $0.45"](0001104659-25-109265|1) | ### Full-year 2025 guidance (as disclosed) | Metric | Guidance range | |---|---:| | Consolidated revenue (USD m) | 640 – 644 ["APEI Consolidated Revenue | $640 – $644"](0001104659-25-109265|1) | | Net income to common (USD m) | 17.2 – 19.6 ["Net income available to common stockholders | $17.2 – $19.6"](0001104659-25-109265|1) | | Adjusted EBITDA (USD m) | 75 – 79 ["Adjusted EBITDA | $75 – $79"](0001104659-25-109265|1) | | Capex (USD m) | 15 – 17 ["Capital Expenditure (CapEx) | $15 – $17"](0001104659-25-109265|1) | --- ## Bottom line (how I’d summarize the APEI setup from these disclosures) APEI’s Q3’25 disclosures show a company with **(1) strong cash generation, (2) APUS-driven profitability, (3) improving RU economics, and (4) fast-growing HCN enrollment**, alongside a very specific near-term macro/regulatory catalyst: the **DoD TA disruption tied to the government shutdown**, which management quantifies as an October registration shock and is actively cost-mitigating. ["Net cash provided by operating activities | 73,516"](0001201792-25-000020|0) ["APUS Segment | $ | 25,280"](0001201792-25-000020|0) ["RU Segment operating margin improved"](0001201792-25-000020|0) ["Total Student Enrollment | 3,700"](0001104659-25-109265|1) ["net course registrations declined by approximately 35%"](0001201792-25-000020|0) If you want to continue the “interactive” dive on your own, the next high-signal sections inside the same 10‑Q are: - **MD&A liquidity + shutdown mitigation** ["Liquidity"](0001201792-25-000020|0) - **Segment drivers (APUS registrations / RU enrollment mix / HCN enrollment)** ["Net course registrations increased"](0001201792-25-000020|0) - **Funding source sensitivity tables (TA/VA/Title IV)** ["derived from students by primary funding source"](0001201792-25-000020|0)